In addition, biomarker nebulin (decreased in urine, correlating with increased risk for relapse; HR = 0.84) was also identified as a promising marker for BC based on the tissue gene expression data correlating with decreased overall survival (p = 0.041). This evidence concerns the gene NEB and breast cancer.